Featured Research

from universities, journals, and other organizations

Early Detection Of Human Papilloma And Other Viral Infections

Date:
October 16, 2007
Source:
American Chemical Society
Summary:
Scientists have developed a new, amazingly sensitive method for identifying the earliest stages of infection with human papilloma virus (HPV), a common virus that can increase the risk of cervical cancer in women. The test also has the potential for early identification of infection with other so-called DNA viruses, which cause a range of diseases that includes genital herpes and hepatitis.

Scientists in Iowa are reporting development of a new, amazingly sensitive method for identifying the earliest stages of infection with human papilloma virus (HPV), a common virus that can increase the risk of cervical cancer in women. The test also has the potential for early identification of infection with other so-called DNA viruses, which cause a range of diseases that includes genital herpes and hepatitis.

In the study, Edward S. Yeung and colleagues point out that the most sensitive existing test for viral infections has drawbacks. That test is the Nobel Prize-winning polymerase chain reaction (PCR), used to detect DNA in settings ranging from medical labs to crime scenes. PCR requires an initial step in which scientists "amplify," or copy, a DNA sample a thousand-fold before virus detection can begin.

However, amplification increases the risk of false-positives and false-negatives, especially when a sample has even a tiny amount of contaminants. Since over 50 million Pap smears are performed in the United States each year to test for HPV -- the leading cause of cervical cancer -- a fast, simple, accurate diagnosis is essential.

The new method skips the amplification step entirely, and yet can detect the presence of less than two copies of HPV per cell -- a level corresponding to very early infection. The technique, called single-molecule spectroscopy, could be easily integrated into the Pap smear method. "It can become a good clinical screening or quantification method for viral DNA in cells," opening the door to improved screening tests for hepatitis B, herpes and other diseases.

Article: "Single-Molecule Detection of Surface-Hybridized Human Papilloma Virus DNA for Quantitative Clinical Screening" Nov. 1 issue of Analytical Chemistry.


Story Source:

The above story is based on materials provided by American Chemical Society. Note: Materials may be edited for content and length.


Cite This Page:

American Chemical Society. "Early Detection Of Human Papilloma And Other Viral Infections." ScienceDaily. ScienceDaily, 16 October 2007. <www.sciencedaily.com/releases/2007/10/071015111653.htm>.
American Chemical Society. (2007, October 16). Early Detection Of Human Papilloma And Other Viral Infections. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2007/10/071015111653.htm
American Chemical Society. "Early Detection Of Human Papilloma And Other Viral Infections." ScienceDaily. www.sciencedaily.com/releases/2007/10/071015111653.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins